General Principle of Action
The action of these drugs is based on the use of chemical structures similar to monosaccharides, purines, and pyrimidines, but with modifications in the heterocyclic ring or carbohydrate component. Once inside the cell, these compounds exert a toxic effect through two main pathways:
- Inhibition of enzymes required for the synthesis of nucleotides or nucleic acids.
- Incorporation into DNA or RNA structure as pseudosubstrates. This disrupts proper complementary base pairing and halts the elongation process of the polynucleotide chain.
Blockade of dTMP Synthesis: Thymidylate Synthase and Dihydrofolate Reductase
The synthesis of deoxythymidine monophosphate (dTMP) from deoxyuridine monophosphate (dUMP) is a critical step for DNA replication prior to cell division. This reaction is catalyzed by the enzyme thymidylate synthase, with a folate derivative ($N^5,N^{10}$-methylene-tetrahydrofolate) serving as the methyl group donor.
During the reaction, tetrahydrofolate is oxidized to dihydrofolate. To prevent the cycle from stalling, dihydrofolate must be reduced back by the enzyme dihydrofolate reductase.
Key chemotherapeutic agents target these two enzymes:
- 5-Fluorouracil selectively blocks thymidylate synthase.
- Methotrexate inhibits the activity of dihydrofolate reductase, depleting active folate stores within the cell.
Mechanisms of Action of Major Drugs
| Drug | Target / Blocked Process | Clinical Application |
|---|---|---|
| 5-Fluorouracil | Inhibits thymidylate synthase after conversion to 5-F-dUMP (suicide inhibitor). Stops dTMP production. | Solid tumors (stomach, lung, breast). |
| Methotrexate | Competitive inhibitor of dihydrofolate reductase. Disrupts purine synthesis and the conversion of dUMP to dTMP due to folate deficiency. | Tumor chemotherapy. |
| Acyclovir | Guanine analog. In its triphosphate form, it incorporates into viral DNA and terminates its synthesis. | Herpes virus infections. |
| Azidothymidine (AZT) | As AZT-triphosphate, it blocks human immunodeficiency virus replication. | HIV/AIDS therapy. |
Suicide Inhibition by 5-Fluorouracil
In the body, 5-fluorouracil (5-F-U) is metabolized into its active form, 5-fluoro-deoxyuridine monophosphate (5-F-dUMP). This metabolite binds to the active site of thymidylate synthase and its coenzyme, attempting to enter the normal methyl transfer reaction.
However, unlike hydrogen in the normal substrate, the fluorine atom is tightly bound to the carbon ring and cannot be cleaved. This results in an irreversible covalent complex, permanently locking the enzyme via a 'suicide' mechanism (suicide inhibition). This leads to 'thymineless death' in cancer cells that are unable to synthesize DNA.
Amino Acid Analogs: Azaserine
Certain antibiotics also interfere with nucleotide synthesis. For example, azaserine is a structural analog of the amino acid glutamine. It acts as a competitive inhibitor of enzymes for which glutamine serves as a nitrogen source.
During de novo purine ring synthesis, glutamine donates nitrogen atoms at positions N3 and N9 and participates in the formation of the GMP amino group. Azaserine blocks these steps by inhibiting the activity of the corresponding enzymes (PRPP glutamine amidotransferase, FGAM synthetase, and GMP synthetase).